Newsroom
Insights
Events
SNMMI Annual Meeting 2026
Oncosia Scientific engaged with the North American nuclear medicine community at SNMMI 2026 — covering multi-nuclide dosimetry, the formal Radnostix distributor launch, and a live demonstration of the integrated EBRT + RLT workflow in PLANET® Dose.
Read64th Annual Meeting of the Deutsche Gesellschaft für Nuklearmedizin (DGN) 2026
Oncosia Scientific's first exhibition presence at DGN — presenting PLANET® Dose, end-to-end clinical trial dosimetry services, and Radnostix calibration & reference sources at Booth A12 in Münster.
ReadXIX National Scientific Congress of the Polish Society of Nuclear Medicine (PTMN) 2026
Oncosia Scientific attended the XIX PTMN Congress in Łódź, contributing patient datasets and PLANET® Dose by DOSIsoft for a live ¹⁷⁷Lu Dosimetry Workshop — covering AI-assisted segmentation, multi-timepoint approaches, and partial volume effect correction.
ReadPress Releases
Oncosia Scientific Becomes First Authorised German Distributor of Radnostix Calibration & Reference Products
Radnostix, Inc. and Oncosia Scientific GmbH announce a distribution agreement making Oncosia Scientific the first authorised distributor of Radnostix calibration and reference products in Germany.
ReadOncosia Establishes Meaningful Foothold in Türkiye: A Growing Market for Personalised Dosimetry
One year after market entry, Oncosia reports first clinical installations, new isotope qualifications, ¹⁶¹Tb trial site qualifications, and a deepening partnership with Siemens Healthineers — with a first clinical publication from Çukurova University.
ReadOncosia Scientific and DOSIsoft Partner to Expand PLANET® Onco Dose in Germany and Türkiye
DOSIsoft SA and Oncosia Scientific GmbH announce their partnership to commercialize and distribute PLANET® Onco Dose across German and Turkish markets — with a shared mission to elevate personalized dosimetry in nuclear medicine.
Read